BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:INN805 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of INN805\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07459283-2549@assetmemo.bio
DTSTAMP:20261121T005423Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:INN805: Phase 1 readout est. (NCT07459283)
DESCRIPTION:INN805\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: The Safe
 ty\, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Sol
 id Tumors\nEstimated primary completion: December 2026. This is a Clinical
 Trials.gov estimate\, not a confirmed readout date\, and it can move.\nDru
 g page: https://assetmemo.bio/drug/inn805#upcoming-events\nRegistry record
 : https://clinicaltrials.gov/study/NCT07459283
URL:https://assetmemo.bio/drug/inn805#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
